Showing 8561-8580 of 8819 for: Cochrane Systematic Reviews Back
- Vaginal dilator therapy for women receiving pelvic radiotherapy
Cochrane Systematic Reviews, 1-Sep-2014
Vaginal dilation therapy is advocated after pelvic radiotherapy to prevent stenosis (abnormal narrowing of the vagina), but can be uncomfortable and psychologically distressing.
- Vaginal disinfection for preventing mother-to-child transmission of HIV infection
Cochrane Systematic Reviews, 5-Sep-2011
Mother-to-child transmission (MTCT) of HIV infection is one of the most tragic consequences of the HIV epidemic, especially in resource-limited countries, resulting in about 650 000 new paediatric HIV infections each year worldwide. The paediatric HIV epi
- Vaginal misoprostol for cervical ripening and induction of labour
Cochrane Systematic Reviews, 20-Nov-2012
Misoprostol (Cytotec, Searle) is a prostaglandin E1 analogue widely used for off-label indications such as induction of abortion and of labour. This is one of a series of reviews of methods of cervical ripening and labour induction using standardised meth
- Vaginal preparation with antiseptic solution before cesarean section for preventing postoperative infections
Cochrane Systematic Reviews, 19-Dec-2014
Cesarean delivery is one of the most common surgical procedures performed by obstetricians. Infectious morbidity after cesarean delivery can have a tremendous impact on the postpartum woman's return to normal function and her ability to care for her baby.
- Vaginal prostaglandin (PGE2 and PGF2a) for induction of labour at term
Cochrane Systematic Reviews, 18-Jun-2014
Prostaglandins have been used for induction of labour since the 1960s. This is one of a series of reviews evaluating methods of induction of labour. This review focuses on prostaglandins given per vaginam, evaluating these in comparison with placebo (or e
- Vagus nerve stimulation for focal seizures
Cochrane Systematic Reviews, 14-Jul-2022
This is an updated version of the Cochrane Review published in 2015.
- Valacyclovir versus acyclovir for the treatment of herpes zoster ophthalmicus in immunocompetent patients
Cochrane Systematic Reviews, 8-Nov-2016
Herpes zoster ophthalmicus affects the eye and vision, and is caused by the reactivation of the varicella zoster virus in the distribution of the first division of the trigeminal nerve. An aggressive management of acute herpes zoster ophthalmicus with sys
- Valerian for anxiety disorders
Cochrane Systematic Reviews, 5-Nov-2008
Anxiety disorders are very common mental health problems in the general population and in primary care settings. Herbal medicines are popular and used worldwide and might be considered as a treatment option for anxiety if shown to be effective and safe.
- Validation therapy for dementia
Cochrane Systematic Reviews, 6-Nov-2008
Validation therapy was developed by Naomi Feil between 1963 and 1980 for older people with cognitive impairments. Initially, this did not include those with organically-based dementia, but the approach has subsequently been applied in work with people who
- Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults
Cochrane Systematic Reviews, 14-May-2014
Some antiepileptic drugs but not others are useful in clinical practice for the prophylaxis of migraine. This might be explained by the variety of actions of these drugs in the central nervous system. The present review is part of an update of a Cochrane
- Valproate for acute mood episodes in bipolar disorder
Cochrane Systematic Reviews, 19-Jun-2015
Valproate has become a leading adjunctive and alternative treatment to lithium in bipolar disorder.
- Valproate for schizophrenia
Cochrane Systematic Reviews, 13-Apr-2010
Many people with schizophrenia do not achieve a satisfactory treatment response with ordinary antipsychotic drug treatment. In these cases, various add-on medications are used; valproate is one of these.
- Valproate preparations for agitation in dementia
Cochrane Systematic Reviews, 9-Nov-2010
Agitation affects up to 70% of older people with dementia. Valproic acid derivatives have been used for the past 10 years to control agitation in dementia, but no systematic review of the effectiveness of this treatment has been published to date. A syste
- Valproic acid and sodium valproate for neuropathic pain and fibromyalgia in adults
Cochrane Systematic Reviews, 26-Feb-2014
Valproic acid and its sodium salt (sodium valproate) are antiepileptic drugs that are sometimes used to treat chronic neuropathic pain and fibromyalgia, although they are not licensed for this use.
- Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder
Cochrane Systematic Reviews, 16-Oct-2013
Bipolar disorder is a recurrent illness that is amongst the top 30 causes of disability worldwide and is associated with significant healthcare costs. In the past, emphasis was placed solely on the treatment of acute episodes of bipolar disorder; recently
- Vancomycin for prophylaxis against sepsis in preterm neonates
Cochrane Systematic Reviews, 22-Oct-2008
Nosocomial, late onset, sepsis occurs in up to 50% of infants of less than 1000gm at birth. The most frequent organism isolated is coagulase negative staphylococcus (CoNS). A number of studies have evaluated the efficacy of prophylactic low dose vancomyci
- Vapocoolants (cold spray) for pain treatment during intravenous cannulation
Cochrane Systematic Reviews, 26-Apr-2016
Intravenous cannulation is a painful procedure that can provoke anxiety and stress. Injecting local anaesthetic can provide analgesia at the time of cannulation, but it is a painful procedure. Topical anaesthetic creams take between 30 and 90 minutes to p
- Vascular access specialist teams for device insertion and prevention of failure
Cochrane Systematic Reviews, 20-Mar-2018
Most people admitted to hospitals worldwide require a vascular access device (VAD). Hundreds of millions of VADs are inserted annually in the USA with reports of over a billion peripheral intravenous catheters used annually worldwide. Numerous reports sug
- Vascular closure devices for femoral arterial puncture site haemostasis
Cochrane Systematic Reviews, 26-Feb-2016
Vascular closure devices (VCDs) are widely used to achieve haemostasis after procedures requiring percutaneous common femoral artery (CFA) puncture. There is no consensus regarding the benefits of VCDs, including potential reduction in procedure time, len
- Vascular endothelial growth factor (VEGF) targeting therapy for persistent, recurrent, or metastatic cervical cancer
Cochrane Systematic Reviews, 4-Mar-2021
Cervical cancer ranks as the fourth leading cause of death from cancer in women. Historically, women with metastatic or recurrent cervical cancer have had limited treatment options. New anti-angiogenesis therapies, such as vascular endothelial growth fact
